The humoral antibody response of pseudorabies-immune pigs to reactivation of latent pseudorabies virus (PRV) was compared with the response following direct exposure to virulent PRV. Nine pigs that had been vaccinated for pseudorabies and later exposed to virulent virus to establish latent infection were given dexamethasone to reactivate latent virus (3 pigs), were exposed oronasally and parenterally to virulent virus (3 pigs), or were kept as nontreated controls (3 pigs). Sera collected from all 9 pigs just before and 3 weeks after treatment were tested by virus neutralization and radioimmunoprecipitation. The 3 pigs exposed directly to virulent virus and 2 of the 3 pigs given dexamethasone had a 4-fold or greater increase in neutralizing antibody titer. All 6 of these pigs had an increase in precipitating antibody activity. Precipitation patterns changed both quantitatively and qualitatively, especially for virus-coded proteins of relatively low molecular weight (<46 K). There were some differences in the precipitation patterns associated with sera of individual pigs. However, there was no clear indication of any difference between the 2 treatment groups and therefore no evidence that reactivation of latent virus is associated with any unique immunologic response that could be detected by radioimmunoprecipitation and used diagnostically. Clinical signs were limited to the 3 pigs that were exposed oronasally and parenterally to virulent virus even though the dexamethasone-treated pigs shed more virus for much longer than did those exposed directly to virus.
Pigs that survive initial infection with pseudorabies virus (PRV) often remain as latently infected carriers of the virus. 1, 2, 6, 8 Such carriers are of epizootiologic importance because virus may be spontaneously reactivated and shed to susceptible pigs by contact, thus perpetuating the infection and often causing additional clinical losses. 7 Although the parameters associated with naturally occurring reactivation are poorly understood, reactivation of PRV can be induced by the administration of corticosteroids, 1, 6 and this method is often used to experimentally investigate latency and reactivation.
Prior studies indicate that both corticosteroid-induced and naturally occurring reactivation of PRV can cause quantitative and qualitative changes in serum precipitating activity for a broad spectrum of PRVinduced proteins. 3, 4 These changes were often particularly striking for viral proteins of relatively low molecular weight (i.e., <46 K) and occurred even when pigs had high titers of virus neutralization (VN) antibodies in their serum at the time of reactivation. Moreover, the increase in precipitating antibodies occurred with or without a concurrent increase in VN antibody titer or virus shedding. Reactivated virus may initiate a wave of replication similar to that which might, for example, follow oronasal or parenteral exposure of immune pigs to a large dose of virulent virus. As a consequence, appreciable amounts of viral antigens could reach immunoresponsive cells, despite the presence of VN antibody, and stimulate a response quantitatively more noticeable for proteins of moderate and low antigenicity, i.e., virus-induced proteins to which the immune system had been sensitized but had, until the time of reactivation, responded poorly. Despite the logic of this argument, however, it was clear that neither of the previous experiments 3,4 provided any definitive evidence to exclude the possibility that reactivation is associated with a unique immunologic response that could be identified by radioimmunoprecipitation (RIP) and used diagnostically.
This study compared the anamnestic response of immune pigs following dexamethasone-induced virus reactivation with the response following parenteral and oronasal exposure to the same strain of virulent virus. Sera collected before and after these treatments were tested for both precipitating and VN antibodies. In addition, nasal and tonsil swabs were collected and tested for the amount and duration of virus shedding.
Materials and methods
From the National Animal Disease Center, Virology Swine Research Unit, Agricultural Research Service, USDA, PO Box 70, Ames, pigs. Nine pigs were obtained from a commercial swine IA 50010. herd that was known to be free of infection with PRV.
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Establishment of latent infection. All 9 pigs were vacci- Table 1 . Isolation of pseudorabies virus (PRV) from nasal and tonsil swabs collected from immune pigs before and after reactivation of latent PRV or exposure to virulent PRV. nated with a commercial PRV vaccine a when they were 7 wk old. All were free of serum VN antibody for PRV at the time of vaccination. Three weeks later, all pigs were exposed oronasally to 5 x 10 7 plaque-forming units (PFU) of virulent PRV (strain Ind-F). All had clinical signs after exposure to virulent virus, but all recovered within 10 days and remained clinically normal thereafter. Based on a previous study of latency following vaccination and subsequent exposure to virulent virus 4 all were presumed to be latently infected with virulent PRV.
Laboratory procedures and reagents. All of the laboratory procedures and reagents used in this study were as previously described. 3, 5 Experimental design. The 9 latently infected pigs were allocated to 3 treatment groups (3 pigs/group) when they were 19 wk old (i.e., 9 wk after exposure to virulent virus). Each group was thereafter housed in a separate isolation room and appropriate precautions were taken to prevent transfer of PRV among groups during care and treatment. Pigs of group 1 were kept as nontreated controls. Pigs of group 2 were each started on a 5-day series of dexamethasone injections as described previously. 3 Pigs of group 3 were each exposed to 200 ml (5 x 10 7 PFU/ml) of virulent PRV (strain Ind-F). Virus was administered by various routes: 35 ml oronasally, 35 ml intravenously, 130 ml subcutaneously at several sites. All pigs were observed twice daily for clinical signs until the experiment was ended 3 wk after treatment had begun. Blood samples were collected from all pigs just before and 3 wk after treatment was begun. All sera were tested for precipitating and VN antibodies for PRV. Nasal and tonsil swabs were collected just before and daily for 10 consecutive days after treatment was begun and were tested for the presence and amount of PRV after submergence in 2 ml of cell culture medium.
Results
Clinical signs. All pigs of group 2 appeared somewhat listless following the series of dexamethasone injections, but none had any unequivocal clinical signs. All pigs of group 3 were severely, but transiently, af-fected clinically following exposure to virulent virus. By late afternoon, i.e., about 6 hours after exposure to virus, they were listless and inappetent and had difficulty in rising and standing. The next day, they appeared to have partially recovered, but they still had difficulty standing. They also ate slowly but eventually consumed all of their usual ration. By the second day after exposure to virulent virus, they appeared to have recovered completely and thereafter remained clinically normal. Pigs of group 1 (controls) remained clinically normal throughout the 3-week interval of the experiment.
Virus isolation. Pseudorabies virus was isolated from
nasal swabs of all 6 pigs and from tonsil swabs of 4 of 6 pigs of groups 2 and 3 ( Table 1 ). In general, virus was isolated only within the first few days after exposure to virulent virus but for a much longer interval and in much greater amounts after treatment with dexamethasone (i.e., after reactivation of latent virus). Virus was not isolated from any of the swabs collected at the same times from the controls (group 1).
Immune response. All 9 pigs had a relatively high (128-5 12) serum VN titer at the time treatments were begun. Three weeks later, the serum VN titers had increased 1 B-fold for 2 of the 3 pigs given dexamethasone, 4.8-fold for each of the 3 pigs exposed to virulent virus, and 2-fold for 1 (no. 3) of the 3 nontreated pigs. During the same interval, serum VN titers remained the same for 1 (no. 6) of the pigs given dexamethasone and decreased 2-fold for 2 (nos. 1,2) of the nontreated pigs (Table 2) .
When aliquots of the same sera were tested by RIP, all pigs given dexamethasone or exposed to virulent virus had an increase in serum precipitating antibodies (Fig. 1 ). In addition, 1 (no. 3) of the 3 control pigs (the same pig that had a 2-fold increase in serum VN titer) had a less marked but clear increase in serum precip- itating antibody. Quantitative and qualitative changes in RIP patterns following either treatment with dexamethasone or exposure to virulent virus were similar ( Fig. 1) .
Discussion
This study indicates that the humoral immune response of pigs following reactivation of latent PRV can be similar to the response following exposure to a large dose of virulent virus. Differences among individuals, especially in regard to RIP patterns (Fig. l) , were much greater than those between the 2 treatment groups. In general, both treatments caused increased VN and precipitating antibody activity. The finding that RIP may be more sensitive than VN as a serologic indicator of reactivation is consistent with previous observations. 3, 4 The VN test indicates that virus was not reactivated for 1 (no. 6) of the 3 pigs given dexamethasone. However, the results of both RIP and virus isolation clearly show otherwise ( Fig. 1, Table 1 ). In addition, the results of RIP suggest that virus was reactivated in 1 (no. 3) of the 3 nontreated pigs, the same pig that had a slight (2-fold) increase in VN titer. The less marked change in precipitation pattern and failure to isolate virus from this pig may simply reflect the extent of naturally occurring reactivation and subsequent replication of PRV, which may often be less than that associated with the administration of large and repeated doses of dexamethasone. The initiating factor for the presumed reactivation of virus in this case may have been the stress associated with daily restraint needed for collection of nasal and tonsil swabs.
In contrast to the results of previous studies, all of the 3 pigs given dexamethasone yielded large amounts of virus (Table 1) ; however, the quantitative and qualitative changes in serum precipitating activity for radiolabeled viral proteins were no greater than those observed in the absence of virus shedding. 3,4 Therefore, reactivation can result in appreciable amounts of viral antigen reaching immunocompetent cells with or without obvious oronasal shedding of virus.
The mechanism by which dexamethasone affects latent infection and perhaps subsequent control of virus replication in pigs is, as yet, unknown. Nevertheless, events leading to nasal shedding of virus can occur very quickly ( Table 1 ). The amount and duration of Figure 1 . Immunoprecipitation of 3% methionine-labeled pseudorabies virus (PRV) proteins. Sera were collected just before (lane 1) and 3 weeks after (lane 2) pigs were started on a 5-day series of dexamethasone injections (pigs 4, 5, 6), were exposed by various routes to a large dose of virulent PRV (pigs 7, 8, 9) , or were kept as nontreated controls (pigs 1, 2, 3). m = molecular weight markers x 10 3 . virus shedding in dexamethasone-treated pigs suggests 2. Gutekunst DE: 1979, Latent pseudorabies virus infection in swine that reactivated virus, presumably from latently in-detected by RNA-DNA hybridization. Am J Vet Res 40:1568fected neurons, may have subsequently replicated ex-1572. 3. Mengeling WL: 1989, Latent infection and subsequent reactitensively in cells of the nasal mucosa. However, even vation of pseudorabies virus in swine exposed to pseudorabies a vary large dose of virulent virus administered oronavirus while nursing immune dams. Am J Vet Res 50: 1658-1666. sally was quickly controlled in pigs with a similar level 4. Mengeling WL, Pirtle EC: 1990, Sequential changes in the huof humoral immunity (Tables 1, 2 ). moral immune response of pigs to pseudorabies virus after vaccination, exposure to virulent virus, and reactivation of latent
